E Camerini

440 total citations
11 papers, 345 citations indexed

About

E Camerini is a scholar working on Pathology and Forensic Medicine, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E Camerini has authored 11 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Genetics and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E Camerini's work include Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Nutrition, Genetics, and Disease (1 paper). E Camerini is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and Nutrition, Genetics, and Disease (1 paper). E Camerini collaborates with scholars based in Italy. E Camerini's co-authors include Franco Berrino, Rudolf Kaaks, Cristina Bellati, Giorgio Secreto, Salvatore Panico, Valeria Pala, Fabio Baticci, G Terno, Federico Bozzetti and Daniela Scarpa and has published in prestigious journals such as Blood, Cancer and British Journal of Cancer.

In The Last Decade

E Camerini

11 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Camerini Italy	6	109	106	61	60	54	11	345
Carolyn F. Piel United States	13	28 0.3×	60 0.6×	17 0.3×	31 0.5×	80 1.5×	24	597
Gürses Şahin Türkiye	12	69 0.6×	84 0.8×	7 0.1×	74 1.2×	37 0.7×	45	372
C Mahasandana Thailand	16	57 0.5×	63 0.6×	4 0.1×	38 0.6×	62 1.1×	39	579
Byoung-Soo Cho South Korea	12	32 0.3×	52 0.5×	7 0.1×	18 0.3×	108 2.0×	34	388
Gary Lipscomb United States	6	58 0.5×	49 0.5×	9 0.1×	8 0.1×	136 2.5×	7	398
J Shiga Japan	12	36 0.3×	37 0.3×	6 0.1×	18 0.3×	66 1.2×	33	509
K. H. Duswald Germany	7	26 0.2×	13 0.1×	20 0.3×	26 0.4×	53 1.0×	15	411
Yoshinobu Fuke Japan	13	45 0.4×	33 0.3×	6 0.1×	26 0.4×	164 3.0×	39	498
Cheryl P. Sanchez United States	15	131 1.2×	95 0.9×	5 0.1×	32 0.5×	9 0.2×	36	615
C.L. Lutcher United States	10	24 0.2×	10 0.1×	25 0.4×	23 0.4×	19 0.4×	34	486

Countries citing papers authored by E Camerini

Since Specialization

Citations

This map shows the geographic impact of E Camerini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Camerini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Camerini more than expected).

Fields of papers citing papers by E Camerini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Camerini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Camerini. The network helps show where E Camerini may publish in the future.

Co-authorship network of co-authors of E Camerini

This figure shows the co-authorship network connecting the top 25 collaborators of E Camerini. A scholar is included among the top collaborators of E Camerini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Camerini. E Camerini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Berrino, Franco, Cristina Bellati, Giorgio Secreto, et al.. (2001). Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial.. PubMed. 10(1). 25–33. 144 indexed citations

2.

Viviani, Simonetta, E Camerini, V. Bonfante, et al.. (1998). Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. British Journal of Cancer. 77(6). 992–997. 27 indexed citations

3.

Nadali, Gianpaolo, Luisa Tavecchia, Elisabetta Zanolin, et al.. (1998). Serum Level of the Soluble Form of the CD30 Molecule Identifies Patients With Hodgkin's Disease at High Risk of Unfavorable Outcome. Blood. 91(8). 3011–3016. 81 indexed citations

4.

Leo, Angelo Di, Emilio Bajetta, Leonardo Ferrari, et al.. (1996). A dose-finding study of lanreotide (A somatostatin analog) in patients with colorectal carcinoma. Cancer. 78(1). 35–42. 5 indexed citations

5.

Scopsi, Lucio, Maria Rita Castellani, Maria Gullo, et al.. (1996). Malignant Pheochromocytoma in Multiple Endocrine Neoplasia Type 2B Syndrome. Case Report and Review of the Literature. Tumori Journal. 82(5). 480–484. 6 indexed citations

6.

Viviani, Simonetta, Paolo Bidoli, E Camerini, et al.. (1993). Chronic Effects of Subcutaneous Interleukin-2 Therapy on Soluble Interleukin-2 Receptors in Advanced Small Cell Lung Cancer. The International Journal of Biological Markers. 8(1). 21–24. 1 indexed citations

7.

Bozzetti, Federico, et al.. (1982). Pathogenesis and predictability of central venous catheter sepsis.. PubMed. 91(4). 383–9. 70 indexed citations

8.

Bozzetti, Federico, et al.. (1980). Effect of different caloric substrates on postoperative protein metabolism.. PubMed. 150(4). 491–8. 2 indexed citations

9.

Camerini, E. (1976). Micromethods in Molecular Biology. Tumori Journal. 62(1). 134–134. 1 indexed citations

10.

Camerini, E, et al.. (1970). Chromatographic studies of aminoacids released in the incubation media of Fasciola hepatica.. PubMed. 18(5). 376–81. 6 indexed citations

11.

Camerini, E, et al.. (1967). Attività biologiche degli acidi nucleici in Anfibi urodeli. Bolletino di zoologia. 34(1-4). 180–181. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact